FDA Approved: FOSAPREPITANT — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Novadoz Pharmaceuticals' Fosaprepitant via original ANDA, making a generic IV antiemetic available for prevention of chemotherapy-induced nausea an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT)